Portfolio companies.
21,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals

919

currently held

Exits tracked

338

hand-checked

Sectors covered

across the portfolio

Countries covered

from every market

Save searches, build watchlists, pick up where you left off. Free, no credit card.

Start free

1,150 companies matching · Page 9 of 23

Company	Sector	Geo	Investor	Entry	Status
AL-S Pharma AG TVM Life Science Innovation	Biotech	Switzerland	TVM Capital Life Science	2016	Active
Alchemab Therapeutics SV7 Impact Medicine Fund	Biotech	UK	SV Health Managers	2019	Active
Alentis HTGF III	Biotech	Switzerland	High-Tech Gruenderfonds (HTGF)	2019	Active
Aleta Biotherapeutics Columbus Life Sciences Fund IV	Biotech	United States	Columbus Venture Partners	2024	Active
Allogenetics GmbH NBank Capital Beteiligungsfonds	Biotech	Germany	NBank Capital	2024	Active
Allogenica Sorbonne Venture	Biotech	France	Aloe Private Equity	2022	Active
ALLOX Sabadell Asabys Health Innovation Investments II	Biotech	Spain	Asabys Partners	2023	Active
Alloy Therapeutics Mubadala Capital Other Investments	Biotech	USA	Mubadala Capital	–	Active
Alveogene Oxford Science Enterprises Balance Sheet	Biotech	UK	Oxford Science Enterprises	2023	Active
AmacaThera Inveready Biotech III	Biotech	Canada	Inveready Asset Management	2020	Active
Amphista Therapeutics Dementia Discovery Fund	Biotech	UK	SV Health Managers	2022	Active
Amply Co-Fund NI	Biotech	United Kingdom	Clarendon Fund Managers	2022	Active
Amply Discovery Ltd QUBIS Ltd	Biotech	UK	Qubis	2021	Active
AMR Bio EMV Capital Evergreen Fund	Biotech	UK	EMV Capital	2025	Active
AnaBios Principia III - Health	Biotech	United States	Principia SGR	2016	Active
AndzonBio AFB Fund II	Biotech	France	AdBio Partners	2024	Active
AndzonBio2 AFB Fund II	Biotech	France	AdBio Partners	2025	Active
Angarus Therapeutics Nara Health Capital	Biotech	Spain	Nara Capital Partners	2022	Active
AntalGenics Inveready Biotech II	Biotech	Spain	Inveready Asset Management	2017	Active
Aptarion Biotech Bioventure Club Deals	Biotech	Germany	Bioventure Management	2017	Active
Aramune Technologies Ltd QUBIS Ltd	Biotech	UK	Qubis	2021	Active
Arctoris Future Planet Fund I	Biotech	UK	Future Planet Capital	2019	Active
Argobio Angelini Ventures	Biotech	France	Angelini Ventures	2021	Active
ArkVax UK Innovation and Science Seed Fund	Biotech	UK	Future Planet Capital	2022	Active
ArsenalBio Hitachi Ventures Fund II	Biotech	United States	Hitachi Ventures	2022	Active
Artax Biopharma Columbus Innvierte Life Science Fund I	Biotech	United States	Columbus Venture Partners	2020	Active
Ascend Advanced Therapies 4BIO Ventures III	Biotech	UK	4Bio Partners	2023	Active
Ascend Gene & Cell Therapies Abingworth Bioventures 8	Biotech	UK	Abingworth	2023	Active
AstronauTx Dementia Discovery Fund	Biotech	UK	SV Health Managers	2019	Active
Atlas Molecular Pharma Inveready Biotech III	Biotech	Spain	Inveready Asset Management	2021	Active
Atrandi Biosciences Vsquared Ventures II	Biotech	Lithuania	Vsquared Ventures	2025	Active
AudioCure HTGF II	Biotech	Germany	High-Tech Gruenderfonds (HTGF)	2012	Active
Aurobac Therapeutics Boehringer Ingelheim Venture Fund	Biotech	France	Boehringer Ingelheim Venture Fund	2023	Active
Auron Therapeutics Apollo Health Ventures Fund II	Biotech	United States	Apollo Health Ventures	2022	Active
Avantea Taste of Italy 2	Biotech	Italy	DeA Capital Alternative Funds SGR	2024	Active
Awen Oncology Development Bank of Wales (Balance Sheet)	Biotech	UK	Development Bank of Wales	2024	Active
Axoltis Pharma Angelor	Biotech	France	ANGELOR	2024	Active
Axovia Therapeutics ALSA Ventures European Biotechnology Fund	Biotech	UK	ALSA Ventures	2023	Active
Barinthus Biotherapeutics Future Planet Fund I	Biotech	UK	Future Planet Capital	2020	Active
Baseimmune IQ Capital Fund III	Biotech	UK	IQ Capital Partners	2021	Active
Batea Oncology, S.L. SODIGA Galicia	Biotech	Spain	XesGalicia	2025	Active
BDI Biotech Inveready Biotech II	Biotech	Spain	Inveready Asset Management	2017	Active
Beacon Therapeutics Oxford Science Enterprises Balance Sheet	Biotech	UK	Oxford Science Enterprises	2023	Active
Bicycle Therapeutics CIC Fund I	Biotech	UK	Cambridge Innovation Capital	2016	Active
Bindbridge Nucleus Capital II	Biotech	United Kingdom	Nucleus Capital	2026	Active
BioAscent Maven Income and Growth VCT 4	Biotech	UK	Maven Capital Partners	2018	Active
Biocross ADE Capital Sodical	Biotech	Spain	Sodical	2011	Active
BiOligo Biotechnology The Carlyle Group Portfolio	Biotech	USA	The Carlyle Group	–	Active
Biomatter UVC Fund IV	Biotech	Lithuania	Unternehmertum Venture Capital Partners	2024	Active
BioOrbit Breega Seed fund	Biotech	UK	Breega	2026	Active